Thermo Fisher Scientific Is A Massive Moneymaking Opportunity

When it comes to scientific breakthroughs, the only thing better than a Nobel Prize is a Nobel Prize with its own hidden way to beat the market. And that’s exactly the opportunity I’m presenting to you today.

It comes to us from the field of gene editing, which actually allows doctors to edit material in human DNA to combat disease. As a biotech investor, I have followed this field for many years. While it stretches back to the 1970's, two women recently shared a Nobel Prize in Chemistry for turning the field on its head. They developed what’s known as Crispr-Cas9, which allows genomic editing at the embryonic level. The Nobel committee described the science as “rewriting the code of life.”

The market for direct use of this platform is growing at 16% per year and will soon be worth roughly $10 billion. And there is a firm pioneering this field that is beating the broad market by more than 45%.

A DNA Discovery

Now then, the Royal Swedish Academy of Sciences just awarded the Nobel Prize in Chemistry to American biochemist Jennifer Doudna of the University of California, Berkeley. She shares the top award given in science with French microbiologist Emmanuelle Charpentier of the Max Planck Institute for Infection Biology. Together, the two developed Crispr-Cas9 in 2012 and had been thought to be good candidates for a Nobel Prize almost from the start.

What they discovered was a way to harness a bacterial defense mechanism against viruses to easily and quickly edit genes. Crispr is the name for special, short bits of DNA in bacteria. This DNA comes from past virus infections. Because of that, bacteria don’t use this DNA directly. After all, they have no interest in making more viruses.

But these Crispr DNA sequences serve as an example of what other virus DNA may look like. So bacteria use Crispr as a primer when they make an enzyme called Cas9. This enzyme looks for any DNA that looks like the Crispr sequence it was primed with. When it finds something similar, it attaches to the new DNA and cuts it apart, rendering it inert.

1 2 3
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.